PREDICTORS OF SERIOUS INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TARGET THERAPY.

被引：0
|
作者：
Koltsova, E. [1 ,2 ]
Lukina, G. [2 ,3 ]
Shmidt, E. [4 ]
Lytkina, K. [5 ]
Zhilyaev, E. [6 ,7 ]
机构：
[1] Org Hlth & Healthcare Management, Res Inst, Moscow, Russia
[2] AS Loginov Moscow Clin Sci Ctr, Moscow, Russia
[3] VA Nasonova Res Inst Rheumatol, Moscow, Russia
[4] NI Pirogov City Clin Hosp, Moscow, Russia
[5] City Clin Hosp, Moscow, Russia
[6] European Med Ctr, Moscow, Russia
[7] Minist Healthcare Russian Federat, Russian Med Acad Continuous Profess Educ, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.6227
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0303
引用
收藏
页码：1447 / 1447
页数：1
相关论文
共 50 条
  • [31] THE RISK OF SERIOUS INFECTIONS IN PATIENTS RECEIVING ANAKINRA FOR RHEUMATOID ARTHRITIS (RA): RESULTS FROM THE BSR BIOLOGICS REGISTER (BSRBR)
    Galloway, James
    Dixon, Will
    Mercer, Louise
    Watson, Kath
    Mark, Lunt
    Hyrich, Kimme
    Symmons, Deborah
    RHEUMATOLOGY, 2010, 49 : I157 - I158
  • [32] Predictors of prostate cancer recurrence in patients receiving primary radiation therapy.
    Hayner-Buchan, A
    Kallakury, BVS
    Gaddipati, R
    Keys, HM
    Rifkin, MD
    Sheehan, CE
    Ambros, R
    Ross, JS
    MODERN PATHOLOGY, 1998, 11 (01) : 84A - 84A
  • [33] SEVERE RESPIRATORY INFECTIONS IN RHEUMATOID ARTHRITIS PATIENTS WITH BIOLOGIC THERAPY. COMPARATIVE STUDY BETWEEN VACCINATED AND NON VACCINATED PATIENTS
    Dominguez, L.
    Rodriguez Cundin, P.
    Dierssen-Sotos, T.
    Calvo-Rio, V.
    Vegas-Revenga, N.
    Corrales, A.
    Palmou-Fontana, N.
    Prieto-Pena, D.
    Calderon-Goercke, M.
    Gonzalez-Gay, M. A.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1018 - 1019
  • [34] Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
    van Dartel, Sanne A. A.
    Fransen, Jaap
    Kievit, Wietske
    Dutmer, Ellen A. J.
    Brus, Herman L. M.
    Houtman, Nella M.
    van de Laar, Mart A. F.
    van Riel, Piet L. C. M.
    RHEUMATOLOGY, 2013, 52 (06) : 1052 - 1057
  • [35] Serious Infections Associated with Tofacitinib in Rheumatoid Arthritis Patients Previously Treated with Methotrexate
    Machado, Marina Amaral de Avila
    Moura, Cristiano S.
    Guerra, Steve Ferreira
    Curtis, Jeffrey R.
    Abrahamowicz, Michal
    Behlouli, Hassan
    Bernatsky, Sasha
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [36] Serious infections during anti-TNFα treatment in rheumatoid arthritis patients
    Favalli, Ennio Giulio
    Desiati, Francesca
    Atzeni, Fabiola
    Sarzi-Puttini, Piercarlo
    Caporali, Roberto
    Pallavicini, Francesca Bobbio
    Gorla, Roberto
    Filippini, Matteo
    Marchesoni, Antonio
    AUTOIMMUNITY REVIEWS, 2009, 8 (03) : 266 - 273
  • [37] Rate of serious infections in patients with rheumatoid arthritis receiving tumor necrosis factor (TNF)-alpha antagonist: A prospective observational study
    Talarico, Rosaria
    Chiara, Stagnaro
    Claudia, Ferrari
    Pasquale, Pepe
    Laura, Bazzichi
    Stefano, Bombardieri
    JOINT BONE SPINE, 2014, 81 (04) : 378 - 379
  • [38] Anti-tumor necrosis factor a therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis
    Schneeweiss, Sebastian
    Setoguchi, Soko
    Weinblatt, Michael E.
    Katz, Jeffrey N.
    Avorn, Jerry
    Sax, Paul E.
    Levin, Raisa
    Solomon, Daniel H.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1754 - 1764
  • [39] CHARACTERISTICS OF PATIENTS RECEIVING DMARD THERAPY FOR RHEUMATOID ARTHRITIS MANAGEMENT
    Boytsov, N. N.
    Bhattacharya, R.
    Saverno, K. R.
    Dixon, L.
    Abbott, P. L.
    Zhang, X.
    Larmore, C. J.
    Datar, M.
    Gaich, C. L.
    Nair, R.
    VALUE IN HEALTH, 2018, 21 : S201 - S202
  • [40] Initiation of rheumatoid arthritis treatments and the risk of serious infections
    Grijalva, Carlos G.
    Kaltenbach, Lisa
    Arbogast, Patrick G.
    Mitchel, Edward F., Jr.
    Griffin, Marie R.
    RHEUMATOLOGY, 2010, 49 (01) : 82 - 90
12345